# South Carolina Hemp Retailers Warn Bill Would Create ‘Monopoly’ for Liquor Stores > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/south-carolina-hemp-retail-policy-liquor-store-monopoly/ > **Published:** 2026-03-24T21:59:31-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:39:52-04:00 > **Clinical Summary:** Explore South Carolina hemp retail policy and concerns about a bill creating a liquor store monopoly affecting hemp product access. --- ✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) landscape. PolicyHempIndustry Why This Matters I notice the title and summary don’t match (one discusses South Carolina hemp retail policy while the other describes [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) collaboration). Assuming you meant the research collaboration summary: clinicians need robust evidence on cannabis therapeutic applications and safety profiles to counsel patients accurately and make informed prescribing decisions. This Yale-McGill research could fill critical knowledge gaps about efficacy for specific conditions and adverse effects that currently limit evidence-based cannabis use in clinical practice. Clinical Summary # Clinical Summary South Carolina is considering legislation that would restrict hemp product sales to liquor stores, a proposal that retailers argue would create an unfair monopoly and limit consumer access to these products. The bill represents a regulatory shift toward centralized distribution control, similar to alcohol oversight in some states, which could significantly impact how patients obtain cannabis-derived products like CBD. This regulatory approach raises concerns about product availability, pricing, and whether patients with medical needs would face barriers to accessing hemp-derived therapeutics through limited retail channels. From a clinical perspective, restricting distribution to liquor stores may create logistical challenges for patients who need consistent access to quality-controlled products and could complicate the patient counseling process by placing hemp products in venues traditionally associated with alcohol rather than pharmacy or medical settings. Additionally, monopolistic distribution could reduce market competition and potentially increase costs for patients seeking hemp-based treatments. Clinicians should monitor state-level regulatory changes in cannabis and hemp distribution, as these policies directly affect their ability to recommend and discuss product access with patients and may influence treatment planning decisions. Dr. Caplan’s Take “What we’re seeing in South Carolina reflects a broader pattern where cannabis regulation gets shaped by existing commercial interests rather than [public health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/) evidence, and that ultimately limits patient access to products that have demonstrated clinical utility while creating artificial scarcity that drives people back to unregulated markets.” Clinical Perspective Regulatory frameworks governing hemp and cannabis product distribution remain fragmented across states, and South Carolina’s proposed legislation illustrates the tension between public health oversight and commercial access that clinicians should understand when counseling patients. The concern that restricting hemp retail to liquor stores could create market monopolies reflects broader questions about how distribution channels influence product quality, labeling accuracy, and consumer safety—factors that directly affect the reliability of information patients receive about potency, contaminants, and drug interactions. Simultaneously, the Yale-McGill collaboration on cannabis therapeutics and risk assessment underscores the scientific community’s ongoing work to establish evidence-based guidance that should ultimately inform both policy and clinical practice. Healthcare providers should recognize that state-level retail regulations often outpace clinical evidence and may not align with medical best practices, creating uncertainty when patients ask about product selection or local legal options. Practically, clinicians should stay informed about their state’s regulatory changes and use this 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+South+Carolina+Hemp+Retailers+Warn+Bill+Would+Create+%27Monopoly%27+for+Liquor+Stores+%40drcaplan&url=https%3A%2F%2Fwww.cannabisequipmentnews.com%2Fnews%2Fnews%2F22963305%2Fsouth-carolina-retailers-warn-bill-would-create-monopoly-for-liquor-stores)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.cannabisequipmentnews.com%2Fnews%2Fnews%2F22963305%2Fsouth-carolina-retailers-warn-bill-would-create-monopoly-for-liquor-stores)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+South+Carolina+Hemp+Retailers+Warn+Bill+Would+Create+%27Monopoly%27+for+Liquor+Stores+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.cannabisequipmentnews.com%2Fnews%2Fnews%2F22963305%2Fsouth-carolina-retailers-warn-bill-would-create-monopoly-for-liquor-stores)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) Related Articles - South Carolina Hemp Retailers Warn Bill Would Create ‘Monopoly’ for Liquor Stores - [CED Digest: 230 Items — March 15, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-clinical-relevance-2026/) - [CED Digest: 436 Items — March 14, 2026](https://cedclinic.com/cannabis-compounds-fatty-liver-disease-2026/) 📰 Source: [https://www.cannabisequipmentnews.com/news/news/22963305/south-carolina-retailers-warn-bill-would-create-monopoly-for-liquor-stores](https://www.cannabisequipmentnews.com/news/news/22963305/south-carolina-retailers-warn-bill-would-create-monopoly-for-liquor-stores) Further Reading Cannabis Policy Wire[Policy Watch: 20 Regulatory Updates — March 20, 2026](https://cedclinic.com/drug-enforcement-controlled-substances-regulatory-policy-2026/) Research DigestCED Regulatory Digest, Since Last Digest, 1 items CED Clinic BlogTaxpayers to fund clear-up of huge illegal waste dumps [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Bill regulating THC edible sales in SC nears Gov. McMaster's desk – WPDE](https://cedclinic.com/south-carolina-thc-edible-regulation/) Learn about the latest legislative efforts in South Carolina regulating THC edible sales and their potential impact on consumers and retailers. [Read More](https://cedclinic.com/south-carolina-thc-edible-regulation/) [Missouri lawmakers send bill banning intoxicating hemp products to governor's desk](https://cedclinic.com/missouri-intoxicating-hemp-ban/) Explore Missouri's legislative actions on hemp products and how they compare to South Carolina's regulatory environment. [Explore Now](https://cedclinic.com/missouri-intoxicating-hemp-ban/) [Texas hemp companies sue over smokable cannabis ban and higher fees – KUT 90.5](https://cedclinic.com/texas-hemp-companies-lawsuit-smokable-cannabis-ban-fees/) Review legal challenges faced by Texas hemp companies that may offer insights into regulatory impacts similar to South Carolina's proposed bill. [Learn More](https://cedclinic.com/texas-hemp-companies-lawsuit-smokable-cannabis-ban-fees/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).